Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Camelia Al-Khzouz"'
Autor:
Romana Vulturar, Adina Chiș, Sebastian Pintilie, Ilinca Maria Farcaș, Alina Botezatu, Cristian Cezar Login, Adela-Viviana Sitar-Taut, Olga Hilda Orasan, Adina Stan, Cecilia Lazea, Camelia Al-Khzouz, Monica Mager, Mihaela Adela Vințan, Simona Manole, Laura Damian
Publikováno v:
Biomedicines, Vol 10, Iss 6, p 1249 (2022)
Glucose transporter type 1 (Glut1) is the main transporter involved in the cellular uptake of glucose into many tissues, and is highly expressed in the brain and in erythrocytes. Glut1 deficiency syndrome is caused mainly by mutations of the SLC2A1 g
Externí odkaz:
https://doaj.org/article/cb97ee3d57a84e7cb61323360b93fe59
Autor:
Cecilia Lazea, Simona Bucerzan, Camelia Al-Khzouz, Anca Zimmermann, Ștefan Cristian Vesa, Ioana Nașcu, Victoria Creț, Mirela Crișan, Carmen Asăvoaie, Diana Miclea, Paula Grigorescu-Sido
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 989 (2021)
Gaucher disease (GD), one of the most common lysosomal disorders, is characterised by clinical heterogeneity. Cardiac involvement is rare and refers to pulmonary hypertension (PH), valvular abnormalities and myocardial infiltrative damage. The aim of
Externí odkaz:
https://doaj.org/article/8175fd31e68e4a10bc3c223b11bb5d41
Autor:
Raluca Maria Vlad, Paula Grigorescu Sido, Simona Bucerzan, Camelia Al-Khzouz, Ioana Naşcu, Eugen Pascal Ciofu
Publikováno v:
Romanian Journal of Pediatrics, Vol 62, Iss 2, Pp 180-190 (2013)
Obiective. Pacienţii cu trisomie 21 au risc crescut de anomalii hematologice. Studiul şi-a propus evaluarea caracteristicilor hematologice ale acestor pacienţi şi corelarea lor cu modifi cările citogenetice. Material şi metodă. Am efectuat u
Externí odkaz:
https://doaj.org/article/f296c1e37b9d4b71b4750994442adc91
Autor:
Raluca Maria Vlad, Paula Grigorescu Sido, Simona Bucerzan, Camelia Al-Khzouz, Ioana Naşcu, Eugen Pascal Ciofu
Publikováno v:
Romanian Journal of Pediatrics, Vol 61, Iss 4, Pp 379-387 (2012)
Obiective. Trisomia 21 este cea mai frecventă cromozomopatie autozomală. Tabloul clinic cuprinde dismorfi sm, retard în dezvoltare şi sindrom malformativ. În prezent, în România diagnosticul citogenetic se stabileşte tardiv. Studiul de faţ
Externí odkaz:
https://doaj.org/article/15b84c98d30b4da2ab8428f35323e811
Autor:
Cecilia Lazea, Simona Bucerzan, Camelia Al-Khzouz, Victoria Cret, Mirela Crisan, Diana Miclea, Paula Grigorescu-Sido
Publikováno v:
Romanian Journal of Cardiology. 31:847-854
Turner syndrome is characterized by growth failure, pubertal delay and different skeletal, cardiovascular and renal malformations. In this study we investigated the prevalence of cardiac abnormalities and the correlation with the karyotype in girls w
Autor:
Cecilia Lazea, Camelia Al-Khzouz, Crina Sufana, Diana Miclea, Carmen Asavoaie, Ioana Filimon, Otilia Fufezan
Publikováno v:
Therapeutics and clinical risk management. 18
Middle aortic syndrome (MAS) is a rare vascular disease representing an important cause of severe hypertension in children. MAS is characterized by segmental or diffuse narrowing of the abdominal and/or distal descending aorta with involvement of the
Autor:
Cecilia, Lazea, Simona, Bucerzan, Mirela, Crisan, Camelia, Al-Khzouz, Diana, Miclea, Crina, Şufană, Gabriel, Cismaru, Paula, Grigorescu-Sido
Publikováno v:
Med Pharm Rep
Marfan syndrome (MFS) is an autosomal dominant inherited disease of the connective tissue with multiorgan involvement (skeleton, cardiovascular, eyes, skin, lungs). Cardiovascular involvement is variable and represents the major cause of morbidity an
Autor:
Cristina Drugan, Camelia Al-Khzouz
Publikováno v:
Acta Endocrinologica (Bucharest). 11:180-188
Autor:
Sorin MAN, Camelia Al-Khzouz
Publikováno v:
Acta Endocrinologica (Bucharest). 11:463-469
Autor:
Cristina Coldea, Egbert Schulze, Cecilia Lazea, Matthias M. Weber, Paula Grigorescu Sido, Camelia Al Khzouz, Anca Zimmermann
Publikováno v:
Clinical Endocrinology. 71:477-484
Summary Objective It remains controversial if glucocorticoid replacement therapy impairs bone mineral density (BMD) in young patients with 21-hydroxylase deficiency. We aimed to analyze the impact of treatment variables, phenotype and genotype on BMD